Aker BioMarine Balance Sheet Health

Financial Health criteria checks 4/6

Aker BioMarine has a total shareholder equity of $189.7M and total debt of $150.2M, which brings its debt-to-equity ratio to 79.2%. Its total assets and total liabilities are $409.0M and $219.3M respectively. Aker BioMarine's EBIT is $4.6M making its interest coverage ratio 0.3. It has cash and short-term investments of $14.9M.

Key information

79.2%

Debt to equity ratio

US$150.20m

Debt

Interest coverage ratio0.3x
CashUS$14.90m
EquityUS$189.70m
Total liabilitiesUS$219.30m
Total assetsUS$409.00m

Recent financial health updates

Recent updates

Aker BioMarine (OB:AKBM) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Nov 08
Aker BioMarine (OB:AKBM) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Aker BioMarine AS' (OB:AKBM) Revenues Are Not Doing Enough For Some Investors

Nov 05
Aker BioMarine AS' (OB:AKBM) Revenues Are Not Doing Enough For Some Investors

At kr102, Is It Time To Put Aker BioMarine AS (OB:AKBM) On Your Watch List?

Aug 20
At kr102, Is It Time To Put Aker BioMarine AS (OB:AKBM) On Your Watch List?

Optimistic Investors Push Aker BioMarine AS (OB:AKBM) Shares Up 25% But Growth Is Lacking

Jul 19
Optimistic Investors Push Aker BioMarine AS (OB:AKBM) Shares Up 25% But Growth Is Lacking

What Does The Future Hold For Aker BioMarine AS (OB:AKBM)? These Analysts Have Been Cutting Their Estimates

Jul 16
What Does The Future Hold For Aker BioMarine AS (OB:AKBM)? These Analysts Have Been Cutting Their Estimates

There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital

Jul 11
There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital

These 4 Measures Indicate That Aker BioMarine (OB:AKBM) Is Using Debt In A Risky Way

Jun 03
These 4 Measures Indicate That Aker BioMarine (OB:AKBM) Is Using Debt In A Risky Way

There's No Escaping Aker BioMarine AS' (OB:AKBM) Muted Revenues

Feb 15
There's No Escaping Aker BioMarine AS' (OB:AKBM) Muted Revenues

There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital

Nov 06
There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital

Estimating The Fair Value Of Aker BioMarine AS (OB:AKBM)

Sep 06
Estimating The Fair Value Of Aker BioMarine AS (OB:AKBM)

We Think You Should Be Aware Of Some Concerning Factors In Aker BioMarine's (OB:AKBM) Earnings

Nov 04
We Think You Should Be Aware Of Some Concerning Factors In Aker BioMarine's (OB:AKBM) Earnings

Aker BioMarine AS' (OB:AKBM) Has Found A Path To Profitability

Apr 13
Aker BioMarine AS' (OB:AKBM) Has Found A Path To Profitability

Aker BioMarine AS (OB:AKBM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Feb 18
Aker BioMarine AS (OB:AKBM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Loss-Making Aker BioMarine AS (OB:AKBM) Set To Breakeven

Jan 07
Loss-Making Aker BioMarine AS (OB:AKBM) Set To Breakeven

Financial Position Analysis

Short Term Liabilities: AKBM's short term assets ($223.7M) exceed its short term liabilities ($60.8M).

Long Term Liabilities: AKBM's short term assets ($223.7M) exceed its long term liabilities ($158.5M).


Debt to Equity History and Analysis

Debt Level: AKBM's net debt to equity ratio (71.3%) is considered high.

Reducing Debt: AKBM's debt to equity ratio has reduced from 227.8% to 79.2% over the past 5 years.

Debt Coverage: AKBM's debt is well covered by operating cash flow (34.6%).

Interest Coverage: AKBM's interest payments on its debt are not well covered by EBIT (0.3x coverage).


Balance Sheet


Discover healthy companies